RxSight (RXST) Free Cash Flow (2020 - 2026)
RxSight filings provide 6 years of Free Cash Flow readings, the most recent being -$2.3 million for Q4 2025.
- On a quarterly basis, Free Cash Flow rose 75.79% to -$2.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$19.3 million, a 13.6% increase, with the full-year FY2025 number at -$19.3 million, up 13.6% from a year prior.
- Free Cash Flow hit -$2.3 million in Q4 2025 for RxSight, down from -$1.8 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $486000.0 in Q3 2024 to a low of -$18.0 million in Q1 2023.
- Median Free Cash Flow over the past 5 years was -$10.2 million (2021), compared with a mean of -$9.6 million.
- Biggest five-year swings in Free Cash Flow: skyrocketed 108.64% in 2024 and later crashed 463.79% in 2025.
- RxSight's Free Cash Flow stood at -$10.5 million in 2021, then plummeted by 52.95% to -$16.1 million in 2022, then soared by 47.99% to -$8.4 million in 2023, then fell by 11.17% to -$9.3 million in 2024, then surged by 75.79% to -$2.3 million in 2025.
- The last three reported values for Free Cash Flow were -$2.3 million (Q4 2025), -$1.8 million (Q3 2025), and -$6.3 million (Q2 2025) per Business Quant data.